Dr Simon Cork a physiology lecturer at Anglia Ruskin University who researches appetite and body weight explains
GLP-1 dose escalation isn't dangerous for most people, but "not dangerous" and "optimally managed" are not the same sentence
PG 70 mg/dL
IGF-1 then mediates many growth and metabolic effects through JAK/STAT signaling pathways [4]
A GP, pharmacist, or specialist clinician can: Review your current medication list for potential interactions, particularly with diabetes medications, anticoagulants, thyroid treatments, and hormonal contraceptives Assess your nutritional status and advise on appropriate supplementation only where deficiencies are confirmed Monitor for adverse effects such as hypoglycaemia, gastrointestinal disturbance, or unexpected changes in blood pressure or heart rate Refer you to appropriate NHS services , including Tier 3 weight management programmes, if you are seeking structured support for obesity Discuss contraception and family planning , as retatrutide should not be used during pregnancy or breastfeeding